Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02466893 · ClinicalTrials.gov registry record · NA
COMPASS Trial: a Direct Aspiration First Pass Technique
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT02466893 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 250 participants.
The verdict
NCT02466893, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of AIS within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours. Mechanical thrombectomy for AIS patients has been shown in clinical trials to be safe up to 8 hours after symptom onset. Recent trials utilizing advanced imaging to identify patients with large vessel occlusions amenable to intra-arterial thrombectomy (IAT) have shown superiority endovascular therapy over medical therapy to result in improved patient functional outcomes. Pilot data utilizing the ADAPT approach has shown superior technical results with similar functional outcomes while lowering procedure time and device costs versus traditional stent retriever as a first line therapy approaches
Interventions
- OTHER Adapt/Standard Stent Retriever (SR) Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02466893
The ClinicalTrials.gov registry entry for NCT02466893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adapt/Standard Stent Retriever (SR) Group is the first listed.
NCT02466893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02466893 about?
NCT02466893 is a clinical study titled "COMPASS Trial: a Direct Aspiration First Pass Technique". Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of AIS within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours. Mechanical thrombectomy for AIS patients has been shown in clinical trials...
What is the current status of trial NCT02466893?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2015-06. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02466893?
The interventions under investigation include: Adapt/Standard Stent Retriever (SR) Group (OTHER).
Who is sponsoring clinical trial NCT02466893?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.